Dental implant therapy in the non-cleft patient is familiar to most oral and maxillofacial surgeons. Understanding the differences in surgical treatment planning in the cleft patient versus the non-cleft patient is the key to highly functional and esthetic long-term outcomes. CBCT and computer-assisted planning, as well as improved technology in grafting and implant materials, result in excellent outcomes. Communication with the restorative team remains of paramount importance in planning treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.coms.2018.12.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Distal tibial fractures are common lower-limb injuries and are generally associated with a high risk of postoperative complications, especially in patients with multiple medical comorbidities. This study sought to ascertain the efficacy of retrograde intramedullary tibial nails (RTN) for treating extra-articular distal tibial fractures in high-risk patients. Between January 2019 and December 2021, 13 patients considered at high risk for postoperative complications underwent RTN fixation.
View Article and Find Full Text PDFThe purpose of the present study was to evaluate and compare the clinical outcomes of two groups of patients subject to bi-cruciate retaining (BCR) or posterior-stabilized (PS) implants. It was hypothesized that patients treated with BCR prostheses would present higher flexion and better clinical and functional results than those treated with PS implants. This prospective study included thirty-two patients treated for primary knee osteoarthritis and assigned to two matched groups for their demographic characteristics and comorbidities.
View Article and Find Full Text PDFProspective study of femoral neck system (FNS) vs. cannulated compression screw (CCS) fixation has not been appropriately reported. We prospectively investigate the efficacy of FNS vs.
View Article and Find Full Text PDFClinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial.
Front Cardiovasc Med
January 2025
Cardiology Service, Hospital Universitario de La Princesa, Madrid, Spain.
Introduction: Vericiguat, an oral stimulator of soluble guanylate cyclase, reduces cardiovascular mortality and hospitalisations in patients with heart failure (HF) and reduced ejection fraction, as demonstrated in the VICTORIA trial. This study assessed the real-world use of vericiguat.
Material And Methods: This cross-sectional, prospective and multicenter registry (VERISEC) included 776 patients from 43 centres in Spain between December 2022 and October 2023.
Minimally invasive mitral valve replacement redo surgery under ventricular fibrillation in a patient with dextrocardia and situs inversus totalis: a case report.
J Cardiothorac Surg
January 2025
Department of Cardiovascular Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79#, Qingchun Road, Hangzhou, 310003, China.
Background: Dextrocardia is a rare cardiac malposition where the heart's normal orientation is reversed and is most commonly associated with situs inversus totalis (SIT). Such cases are technically challenging when heart surgery is needed, especially re-do surgery.
Case Presentation: A 72-year-old female patient was referred to our hospital with complaints of chest tightness and reduced activity tolerance.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!